Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,578.03
-21.2968-1.33%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,598.74
Open:1,598.63
Low:1,570.99
Close:1,599.33
Volume:60.88M
Turnover:5.18B
Market Cap:1.64T
Float Cap:1.58T

Loading ...

Pfizer's Tilrekimig Phase 3 Program Seen as Potential Upside Driver, UBS Says

MT Newswires Live
·
Sep 28

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Taking Ozempic? a Routine Eye Exam Could Help You Understand Your Risk for Vision Loss

Dow Jones
·
Sep 28

Eli Lilly price target raised to $1,500 from $1,400 at JPMorgan

TIPRANKS
·
Sep 28

Lilly Launches Initiative to Expand Diabetes, Obesity Drug Access

MT Newswires Live
·
Sep 28

Eli Lilly launches ‘Lilly Change the Course Commitment’

TIPRANKS
·
Sep 28

Pfizer to Present Phase 3 SigVie-002 Survival Data for Sigvotatug Vedotin in Previously Treated NSCLC at ESMO 2026

Reuters
·
Sep 28

Eli Lilly - to Register Diabetes and Obesity Medicines in Lmics and Expand Access

THOMSON REUTERS
·
Sep 28

Eli Lilly - Aims to Treat Equal Number of Patients in Lmics and High-Income Countries by 2040

THOMSON REUTERS
·
Sep 28

JPMorgan Adjusts Price Target on Eli Lilly to $1,500 From $1,400, Maintains Overweight Rating

MT Newswires Live
·
Sep 28

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 28

Eli Lilly's Olumiant Gets FDA Approval for Severe Alopecia Areata in Adolescents

MT Newswires Live
·
Sep 28

Nektar selloff on trial brings ‘strong entry point,’ says BTIG

TIPRANKS
·
Sep 28

ETF Weekly | QCML Soars 27%; INTW, AMUU, FBL, AMDL Jump 26%; SOXL Rallies 22%; Semiconductor Longs Lead

ETF Weekly
·
Sep 27

Pfizer (PFE) Bets Big on RSV and Cancer Care

TIPRANKS
·
Sep 26

Viking Therapeutics Rallies as Obesity Drug Hopes Rise

TIPRANKS
·
Sep 26

Novo Nordisk (0QIU) Receives a Hold from Bank of America Securities

TIPRANKS
·
Sep 26

Eli Lilly Gets Expanded Label Approval from FDA for Alopecia Drug

Dow Jones
·
Sep 26

FDA Approves Lilly's Olumiant (Baricitinib) for Pediatric Patients 12 Years of Age and Older with Severe Alopecia Areata

THOMSON REUTERS
·
Sep 26

Dow's 500-Point Rally Highlighted by Gains in Shares of Microsoft, Sherwin-Williams Co.

Dow Jones
·
Sep 26